Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States

Journal of Toxicology and Environmental Health - Part A: Current Issues

Volumn 73, Issue 19, 2010, Pages 1283-1287

  McElroy, Jane A ^a,b   Bryda, Elizabeth C ^c   McKay, Stephanie D ^b   Schnabel, Robert D ^b   Taylor, Jeremy F ^b  

^a Family and Community Medicine Department   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c Veterinary Pathobiology Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; DNA; METALLOTHIONEIN II;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DNA EXTRACTION; DNA ISOLATION; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HUMAN; NORMAL HUMAN; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; SALIVA; SAMPLE; SINGLE NUCLEOTIDE POLYMORPHISM; SPECTROPHOTOMETER; UNITED STATES;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; METALLOTHIONEIN; MIDDLE AGED; MIDWESTERN UNITED STATES; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC;

EID: 77955595354     PISSN: 15287394     EISSN: 10872620     Source Type: Journal    
DOI: 10.1080/15287394.2010.485067     Document Type: Article

References (19)

1. Akesson, A., Julin, B., and Wolk, A. 2008. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: A population-based prospective cohort study. Cancer Res. 68:6435-6441.
2. Beyersmann, D., and Hechtenberg, S. 1997. Cadmium, gene regulation, and cellular signalling in mammalian cells. Toxicol. Appl. Pharmacol. 144:247-261.
3. Bjorkman, L., Vahter, M., and Pedersen, N. L. 2000. Both the environment and genes are important for concentrations of cadmium and lead in blood. Environ. Health Perspect. 108:719-722.
4. Elinder, C. G. 1985. Normal values for cadmium in human tissues, blood, and urine in different countries. In Cadmium and health: A toxicological and epidemiological appraisal, Volume I, Exposure, dose, and metabolism, eds. L. Friberg, C. G. Elinder, T. Kjellstrom, and G. F. Nordberg, pp. 81-102. Boca Raton, FL: CRC Press.
5. Friberg, L., Elinder, C. G., Kjellstrom, T., and Nordberg, G. F. 1985a. Cadmium and health: A toxicological and epidemiological appraisal, Volume I, Exposure, dose, and metabolism. Boca Raton, FL: CRC Press.
6. Friberg, L., Elinder, C. G., Kjellstrom, T., and Nordberg, G. F. 1985b. Cadmium and health: A toxicological and epidemiological appraisal, Volume II, Effects and response. Boca Raton, FL: CRC Press.
7. Giacconi, R., Caruso, C., Lio, D., Muti, E., Cipriano, C., Costarelli, L., Saba, V., Gasparini, N., Malavolta, M., and Mocchegiani, E. 2007a. CD14 C (-260)T polymorphism, atherosclerosis, elderly: Role of cytokines and metallothioneins. Int. J. Cardiol. 120:45-51.
8. Giacconi, R., Caruso, C., Malavolta, M., Lio, D., Balistreri, C. R., Scola, L., Candore, G., Muti, E., and Mocchegiani, E. 2008. Pro-inflammatory genetic background and zinc status in old atherosclerotic subjects. Ageing Res. Rev. 7:306-318.
9. Giacconi, R., Cipriano, C., Muti, E., Costarelli, L., Maurizio, C., Saba, V., Gasparini, N., Malavolta, M., and Mocchegiani, E. 2005. Novel-209A/G MT2A polymorphism in old patients with type 2 diabetes and atherosclerosis: Relationship with inflammation (IL-6) and zinc. Biogerontology 6:407-413.
10. Giacconi, R., Muti, E., Malavolta, M., Cipriano, C., Costarelli, L., Bernardini, G., Gasparini, N., Mariani, E., Saba, V., Boccoli, G., and Mocchegiani, E. 2007b. The +838 C/G MT2A polymorphism, metals, and the inflammatory/immune response in carotid artery stenosis in elderly people. Mol. Med. 13:388-395.
11. Jarup, L., Berglund, M., Elinder, C. G., Nordberg, G., and Vahter, M. 1998. Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand. J. Work Environ. Health 24:1-51.
12. Kayaalti, Z., and Soylemezoglu, T. 2010. The polymorphism of core promoter region on metallothionein 2A-metal binding protein in Turkish population. Mol. Biol. Rep. 37: 185-190.
13. Kita, K., Miura, N., Yoshida, M., Yamazaki, K., Ohkubo, T., Imai, Y., and Naganuma, A. 2006. Potential effect on cellular response to cadmium of a single-nucleotide A- G polymorphism in the promoter of the human gene for metallothionein IIA. Hum. Genet. 120:553-560.
14. Klaassen, C. D. 1981. Pharmacokinetics in metal toxicity. Fundam. Appl. Toxicol. 1: 353-357.
15. Klaassen, C. D., Liu, J., and Choudhuri, S. 1999. Metallothionein: An intracellular protein to protect against cadmium tox-icity. Annu. Rev. Pharmacol. Toxicol. 39: 267-294.
16. Masters, B. A., Kelly, E. J., Quaife, C. J., Brinster, R. L., and Palmiter, R. D. 1994. Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium. Proc. Natl. Acad. Sci. USA 91:584-588.
17. McElroy, J. A., Shafer, M. M., Trentham-Dietz, A., Hampton, J. M., and Newcomb, P. A. 2006. Cadmium exposure and breast cancer risk. JNCI 98:869-873.
18. Morsci, N. S., Schnabel, R. D., and Taylor, J. F. 2006. Association analysis of adiponectin and somatostatin polymorphisms on BTA1 with growth and carcass traits in Angus cattle. Anim. Genet. 37:554-562.
19. Yang, L., Li, H., Yu, T., Zhao, H., Cherian, M. G., Cai, L., and Liu, Y. 2008. Polymorphisms in metallothionein-1 and-2 genes associated with the risk of type 2 diabetes mellitus and its complications. Am. J. Physiol. Endocrinol. Metab. 294:E987-E992.